HJS and DHJS, two near-infrared emissive
and mitochondria-targeted
therapy probes, have been designed. They exhibited photothermal &
photodynamic cytotoxicity and aggregation-induced emission (AIE) characteristics.
Interestingly, we could receive fluorescence immediately after adding
the probes without washing in 1 min. They could quickly enter cancer
cells and selectively localized to the mitochondria firstly. When
the concentration of probes was low (<5 μM), they could respond
sensitively to the mitochondrial membrane potential and would selectively
enter the mitochondria with red fluorescence. However, when the concentration
was high (≥5 μM), they would preferentially enter the
mitochondria and have the property of dual-channel fluorescence imaging
(red and near-infrared) even after 24 h. What’s more, they
increased the intracellular reactive oxygen species (ROS) levels,
decreased the mitochondrial membrane potentials, and then induced
apoptosis, which were proved by confocal imaging and flow cytometry
experiments. In addition, the results of photothermal experiment and
cytotoxicity test showed that the probes had good photothermal and
photodynamic toxicity to cancer cells. In vitro and in vivo experiments also proved the excellent near-infrared
(NIR) imaging ability, good biocompatibility and certain inhibition
of tumor growth ability of DHJS.